期刊文献+

尿毒营养膏对尿毒症维持性血透(MHD)患者的微炎症状态的影响 被引量:1

Influence of Niaodu cream on micro inflammation in MHD patients
下载PDF
导出
摘要 目的:研究尿毒营养膏对维持性血液透析患者微炎症状态的影响。方法:将60例尿毒症维持性血液透析患者随机分为治疗组、对照组各30例。两组均给予常规治疗,治疗组在常规治疗基础上加服尿毒营养膏,疗程12周。观察两组在治疗前后基础营养指标、血红蛋白(HGB)、血清白蛋白(ALB)、C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、β2-微球蛋白的水平。结果:两组患者治疗前后营养状况的比较有显著差异(P<0.05),治疗组HGB水平较治疗前上升,较对照组有统计学差异(P<0.05),治疗组ALB水平上升但无统计学意义(P>0.05),治疗组hs-CRP、IL-6水平较治疗前下降且低于对照组(P<0.05),治疗组β2-微球蛋白水平有下降趋势,但无统计学意义。结论:尿毒营养膏可以改善维持性血液透析患者的营养状况,降低维持性血液透析患者的CRP、IL-6水平,能提升HGB水平,改善其贫血状态。 Objective: To observe clinical influence of Niaodu cream on micro inflammation in MHD patients. Methods: 60 patients were randomly divided into two groups, 30 cases for each. All groups were given routine medicine, the treatment was given Niaodu cream more, basic nutrition indicators, HGB, ALB, hs-CRP, IL-6,β2-microglobulin levels were compared before and after treatment. Results: The difference of nutritional status between two groups was obvious (P〈0.05), HGB levels in the treatment was higher with a statistical differencethan that before treatment (P〈0.05), while ALB levels in the treatment was higher with no statistical difference (P〉0.05), hs-CRP, IL-6 levels in the treatment was reduced and lower than that in the control (P〈0.05),β2-microglobulin levels in the treatment tend to be reduced with no statistical significance. Conclusion: Niaodu cream can improve nutritional status and reduce CRP, IL-6 levels in MHD patients, improve anemia status through adjustment of HGB levels.
作者 王泽兰 孙静
出处 《中医临床研究》 2014年第14期13-15,共3页 Clinical Journal Of Chinese Medicine
关键词 尿毒营养膏 血液透析 微炎症状态 Niaodu cream Hemodialysis Micro-inflammatory state
  • 相关文献

参考文献5

  • 1Locatelli F, Manzoni C, Di Filippo S.The importance of convective transport[J].Kidney Int Suppl,2002,80:115-120.
  • 2Schomig M, Eisenhardt A, Ritz E. The microinfl amm at ory state ofu remi a[J].Blood Purif,2000,18(4):327-332.
  • 3Kaysen GA. The microinfl am mat ory s tat e in u remia: causes and pot ant ial consequences.J Am Soc Nephrol, 2001,12(7): 1549-1557.
  • 4JoumosiD.Hemofiltrationduringeardiopulmonarybypass[J].Kideylnt, 1998,53, (66):174-181.
  • 5Craddock PR, Fehr J, Dalmasso AP, et al. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.J Clin Invest ,1977,59(5):879-888.

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部